Holymox KT Eye Drop is a combination ophthalmic solution containing Ketorolac tromethamine (0.4% w/v) and Moxifloxacin hydrochloride (0.5% w/v), formulated for the management of ocular inflammation and bacterial infections. Ketorolac, a non-steroidal anti-inflammatory drug (NSAID), exerts its effect by inhibiting cyclooxygenase enzymes, thereby reducing the synthesis of prostaglandins responsible for inflammation, pain, and edema. Moxifloxacin, a fourth-generation fluoroquinolone antibiotic, offers broad-spectrum antibacterial activity by inhibiting bacterial DNA gyrase and topoisomerase IV, essential enzymes for bacterial DNA replication and transcription. Holymox KT Eye Drop is indicated for the treatment of bacterial conjunctivitis, keratitis, and post-operative inflammation where bacterial infection risk is present. The dual-action formulation provides both anti-inflammatory and antimicrobial effects, facilitating faster recovery and symptom relief. It is typically administered as one or two drops into the affected eye(s) every 6 to 8 hours, as directed by a healthcare professional. Caution is advised in patients with hypersensitivity to NSAIDs or fluoroquinolones. Use during pregnancy and lactation should be under medical supervision. Adverse effects may include transient burning or stinging upon instillation, ocular irritation, or hypersensitivity reactions. Proper hygiene and adherence to prescribed dosing are essential to prevent contamination and ensure therapeutic efficacy.